Drug Profile
HIV vaccine - Sanofi
Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Sanofi
- Class AIDS vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 30 Nov 2020 Discontinued - Phase-II for HIV infections in France (Parenteral) (Sanofi pipeline, November 2020)
- 08 Feb 2017 Phase-II clinical trials in HIV infections in France (Parenteral)